Gates Foundation Awards $38M To Takeda Pharmaceuticals To Develop Low-Cost Polio Vaccine

Reuters: Gates Foundation backs Takeda polio vaccine with $38 million grant
“Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. … Chris Elias, the Gates Foundation’s head of global development, said the partnership would help ‘ensure that the world has enough vaccine to get the job done and maintain a polio-free world’…” (Kelland, 5/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.